Drug Type Monoclonal antibody |
Synonyms BCD-100, Forteca |
Target |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date RU (01 Apr 2020), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Melanoma | RU | 01 Apr 2020 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic melanoma | Phase 3 | RU | 01 Feb 2022 | |
Unresectable Melanoma | Phase 3 | RU | 01 Feb 2022 | |
Uterine Cervical Cancer | Phase 3 | CN | 13 May 2021 | |
Uterine Cervical Cancer | Phase 3 | RU | 13 May 2021 | |
Metastatic Non-Squamous Non-Small Cell Lung Carcinoma | Phase 3 | CN | 08 Apr 2021 | |
Metastatic Non-Squamous Non-Small Cell Lung Carcinoma | Phase 3 | CN | 08 Apr 2021 | |
Advanced Cervical Carcinoma | Phase 3 | CN | 01 Oct 2019 | |
Advanced Cervical Carcinoma | Phase 3 | GE | 01 Oct 2019 | |
Advanced Cervical Carcinoma | Phase 3 | RU | 01 Oct 2019 | |
Advanced Cervical Carcinoma | Phase 3 | TR | 01 Oct 2019 |
Not Applicable | 4 | xgucgptwsh(kzortzfcjw) = <1% tgajpjpjjo (gxonqviqsc ) View more | - | 08 Jun 2023 | |||
Not Applicable | 7 | rumrqlrmza(tduzpthkfe) = upjalddntq fiftgifych (wapqfmftuc ) | Positive | 31 May 2023 | |||
Phase 2 | 58 | oerjnishec(dgerktpils) = lpolbrmvoh pbbsipsutn (nrhusbpfau ) View more | Positive | 31 May 2023 | |||
Phase 2 | 126 | tlnrumbfaz(kjbaxjgdfy) = ipmezrdeyy nzwvmoltvi (cbpwiwjktm ) View more | Positive | 16 Apr 2021 | |||
tlnrumbfaz(kjbaxjgdfy) = eupzquxxkp nzwvmoltvi (cbpwiwjktm ) View more |